Crinetics Pharmaceuticals... (CRNX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
36.99
1.37 (3.85%)
At close: Jan 15, 2025, 10:29 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | 4.01M | 4.74M | 1.08M | 71.00K | 1.19M | 2.43M | 2.04M | 589.00K |
Cost of Revenue | n/a | 1.39M | 1.26M | 57.00M | 1.11M | 24.48M | 9.23M | 5.10M |
Gross Profit | 4.01M | 3.35M | -184.00K | -56.93M | 80.00K | -22.05M | -7.19M | -4.51M |
Operating Income | -222.61M | -167.88M | -107.70M | -74.95M | -53.83M | -28.71M | -9.13M | -6.04M |
Interest Income | 13.44M | 4.32M | 157.00K | 991.00K | 3.46M | 1.75M | 26.00K | 37.00K |
Pretax Income | -214.53M | -163.92M | -107.64M | -73.81M | -50.42M | -27.11M | -9.16M | -6.02M |
Net Income | -214.53M | -159.95M | -106.72M | -72.86M | -49.53M | -27.11M | -9.16M | -6.02M |
Selling & General & Admin | 58.09M | 42.39M | 24.52M | 18.03M | 13.52M | 6.66M | 1.94M | 1.53M |
Research & Development | 168.53M | 130.22M | 84.25M | 57.00M | 41.51M | 24.48M | 9.23M | 5.10M |
Other Expenses | n/a | 4.97M | 61.00K | -71.00K | -1.19M | 1.59M | -48.00K | -1K |
Operating Expenses | 226.62M | 172.62M | 108.78M | 74.95M | 53.83M | 28.71M | 9.13M | 6.04M |
Interest Expense | n/a | 4.32M | n/a | n/a | n/a | n/a | 8.00K | 11.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 226.62M | 172.62M | 108.78M | 74.95M | 53.83M | 28.71M | 9.13M | 6.04M |
Income Tax | n/a | -3.96M | -922.00K | -948.00K | -887.00K | 1.59M | -40.00K | 10.00K |
Shares Outstanding (Basic) | 58.07M | 51.98M | 38.44M | 30.45M | 24.18M | 12.14M | 13.88M | 13.88M |
Shares Outstanding (Diluted) | 58.07M | 51.98M | 38.44M | 30.45M | 24.18M | 12.14M | 13.88M | 13.88M |
EPS (Basic) | -3.69 | -3.08 | -2.78 | -2.39 | -2.05 | -2.23 | -0.66 | -0.43 |
EPS (Diluted) | -3.69 | -3.08 | -2.78 | -2.39 | -2.05 | -2.23 | -0.66 | -0.43 |
EBITDA | -221.51M | -166.90M | -106.78M | -72.59M | -49.31M | -28.24M | -9.00M | -5.95M |
Depreciation & Amortization | 1.10M | 1.39M | 1.26M | 1.23M | 1.11M | 471.00K | 128.00K | 92.00K |